The therapeutic actions of DPP-IV inhibition are not mediated by glucagon-like peptide-1

Diabetologia. 2005 Apr;48(4):608-11. doi: 10.1007/s00125-005-1704-8. Epub 2005 Mar 11.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Deaminase / metabolism
  • Adenosine Deaminase Inhibitors*
  • Blood Glucose / metabolism
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Dipeptidyl Peptidase 4 / metabolism
  • Enzyme Inhibitors / adverse effects
  • Enzyme Inhibitors / pharmacology
  • Enzyme Inhibitors / therapeutic use
  • Gastric Emptying / drug effects
  • Glucagon / blood
  • Glucagon / metabolism
  • Glucagon / physiology*
  • Glucagon-Like Peptide 1
  • Glycoproteins / antagonists & inhibitors*
  • Glycoproteins / metabolism
  • Homeostasis / drug effects
  • Humans
  • Nausea / chemically induced
  • Peptide Fragments / blood
  • Peptide Fragments / metabolism
  • Peptide Fragments / physiology*
  • Protein Precursors / blood
  • Protein Precursors / metabolism
  • Protein Precursors / physiology*
  • Vomiting / chemically induced

Substances

  • Adenosine Deaminase Inhibitors
  • Blood Glucose
  • Enzyme Inhibitors
  • Glycoproteins
  • Peptide Fragments
  • Protein Precursors
  • Glucagon-Like Peptide 1
  • Glucagon
  • DPP4 protein, human
  • Dipeptidyl Peptidase 4
  • Adenosine Deaminase